Screening for CDC73-related disorders has high clinical value because of the risk for parathyroid carcinoma, tumors of the kidney and uterus that may also be malignant, and the potential for locally aggressive jaw tumors. This evidence concerns the gene CDC73 and parathyroid gland carcinoma.